Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
about
Yoga for secondary prevention of coronary heart diseaseYoga for secondary prevention of coronary heart diseaseYoga for secondary prevention of coronary heart disease"Platelet-associated regulatory system (PARS)" with particular reference to female reproductionAspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status.Safety and tolerability of extended-release acetylsalicylic acid capsules: a summary of double-blind comparative studies.Proteome-wide prediction of targets for aspirin: new insight into the molecular mechanism of aspirin.
P2860
Q24186604-86269389-6588-4EA1-A7D1-F669A4330481Q24187259-BC4ACD58-169C-40EF-B35C-6EA376F85254Q24202534-8D642F85-E67A-4DC1-99E9-C2B2355E3D4AQ33690681-532ABA88-18DB-4E98-A7BE-A2C85F6B501FQ34433987-02C156C0-8F56-4714-BF38-7686FCDED3ACQ38801769-280F0C9E-2269-4946-BC71-E2CDBBD478C4Q39028044-92947D39-2362-43C3-819E-3F44EAAAD020
P2860
Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
@en
type
label
Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
@en
prefLabel
Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
@en
P2093
P2860
P356
P1476
Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
@en
P2093
Michael Erbach
Michael Hummel
Oliver Schnell
P2860
P304
P356
10.1177/1479164112441486
P407
P577
2012-04-16T00:00:00Z